VIENNA—Obesity and insulin resistance were named as important targets for primary prevention of breast cancer by Pamela J. Goodwin, MD, MSc, FRCPC, Professor of Medicine and Director of the Marvelle Koffler Breast Centre at the University of Toronto/Mount Sinai Hospital, Canada. Oncology Times reporter Sarah Maxwell asked her about the findings and recommendations to cancer doctors emerging from her long term investigations of these factors.
You may also like...
Physical Therapy Survey Shows Clinical Practice Guideline Brought Benefit 19 Oct, 2017 Acute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid? 18 Dec, 2012 Audio Journal of Oncology in Advance – April 1st, 2007 – reporting From: Journal of Clinical Oncology, January 20th, 2007 & December 20, 2006 2 Apr, 2007 Idelalisib: new targeted therapy improves outlook for patients with chronic lymphocytic leukaemia 24 Jan, 2014
- Previous story Targeting Bone Microenvironment in Breast Cancer
- Next story Targeting Emerging Drugable Pathways in Breast Cancer—Clinical Potential Assessed
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014